Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Sleepiness, cognitive performance, and quality of life are overlapping aspects of daytime function that may be affected in patients with obstructive sleep apnoea/hypopnoea syndrome. The evidence is compatible with hypotheses that these deficits are reversible with treatment, particularly for patients with severe disease.

Is there a familial association between obstructive sleep apnoea/hypopnoea and the sudden infant death syndrome?

Background: One postulated cause of the sudden infant death syndrome (SIDS) is upper airway obstruction during sleep. Several studies have suggested that SIDS may be more common in families with obstructive sleep apnoea/hypopnoea syndrome (OSAHS), but were limited by uncertainty as to whether the deaths were due to SIDS. We have tested the hypothesis that parents of true SIDS cases have an increased frequency of apnoeas and hypopnoeas during sleep.

Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS).

Though continuous positive airway pressure (CPAP) is the treatment of choice for the sleep apnoea/hypopnoea syndrome (SAHS), suboptimal adherence to CPAP is common. Internationally, some 5-50% of SAHS patients recommended for CPAP either reject this treatment option or discontinue within the first week, and 12-25% of remaining patients can be expected to have discontinued CPAP by 3 years. Biomedical investigations of patients' CPAP use reveal frequent adverse effects, weak prospective relationships between symptomatic or physiological disease severity and CPAP use, and moderate correlations between use and benefit.

The upper airway in pregnancy and pre-eclampsia.

Snoring is common in pregnancy, and snoring pregnant women have increased rates of pre-eclampsia. Patients with pre-eclampsia show upper airway narrowing during sleep. The present study aimed to compare upper airway dimensions in pregnant and nonpregnant women and in patients with pre-eclampsia.

Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint.

Mandibular repositioning splints (MRSs) and continuous positive airway pressure (CPAP) are used to treat the sleep apnea/hypopnea syndrome (SAHS). There are some data suggesting that patients with milder symptoms prefer MRS, but there are few comparative data on outcomes. Therefore, we performed a randomized crossover trial of 8 weeks of CPAP and 8 weeks of MRS treatment in consecutive new outpatients diagnosed with SAHS (apnea/hypopnea index [AHI] >or= 5/hour, and >or= 2 symptoms including sleepiness).

Excessive daytime sleepiness and the sleep apnoea/hypopnoea syndrome: a major public health problem?

There is unequivocal evidence that the sleep apnoea/hypopnoea syndrome (SAHS) causes daytime sleepiness and a consequential increase in road accidents. There is not, however, good agreement about the magnitude of that increase in risk. Estimates for the increased risk range from 1.

Does the physiological success of CPAP titration predict clinical success?

Patients commencing continuous positive airway pressure therapy (CPAP) undergo overnight airway pressure titration in sleep centres to optimize breathing and sleep patterns. We tested the hypothesis that data from formal scoring of the sleep and breathing patterns observed at the best achievable pressure during titration can predict CPAP use and effectiveness, as our clinical experience suggested otherwise. The relationship between CPAP titration scores (apnoea/hypopnoea frequency, arousal frequency and sleep staging) and subsequent CPAP use was examined in 150 sleep apnoea/hypopnoea syndrome patients.